Elekta divests its stake in ViewRay

STOCKHOLM,Jan. 22,2021 -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay,Inc. (Nasdaq:VRAY). Elekta has no remaining shares in ViewRay after the transaction.

The shares in ViewRay were purchased in a public offering in December 2019 at USD 3.13 per share and sold today at USD 4.65 per share. The proceeds from the sale were approximately USD 53 million,resulting in a gain of approximately USD 17.5 million. The gain will be booked in Elekta's third quarter 2020/21.

For further information,please contact:

Mattias Thorsson,VP Corporate Communications

Tel: +46 70 865 8012

e-mail:Mattias.Thorsson@elekta.com

Time zone: CET: Central European Time

Cecilia Ketels,Head of Investor Relations

Tel: +46 76 611 76 25

e-mail: cecilia.ketels@elekta.com

Time zone: CET: Central European Time

This is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CET on January 22,2021. (REGMAR)

About Elekta

For almost five decades,Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise,personalized radiotherapy treatments. Headquartered in Stockholm,Sweden,Elekta is listed on NASDAQ Stockholm Exchange. Visitelekta.comor follow @Elekta on Twitter.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/elekta/r/elekta-divests-its-stake-in-viewray,c3272256

The following files are available for download:

https://mb.cision.com/Main/35/3272256/1362202.pdf

Release